Enovix (ENVX) CLO has shares withheld to cover RSU tax obligations

Rhea-AI Filing Summary

Enovix Corp Chief Legal Officer Arthi Chakravarthy reported routine share withholding transactions related to vesting stock awards. On January 8, 2026, a total of 4,361 shares of Enovix common stock were withheld at $7.91 per share to cover tax obligations from the vesting of restricted stock units. After these transactions, Chakravarthy beneficially owned 410,459 shares of common stock directly.

The filing notes that this total includes 289,249 shares issuable upon future vesting and settlement of RSUs and 20,786 vested performance RSUs, with half of those PRSUs scheduled for release on March 2, 2026 and the remainder on March 1, 2027. A separate ownership line reflects 282,906 RSU-based shares plus the same 20,786 vested PRSUs, underscoring that a significant portion of the position is tied to ongoing equity awards rather than currently settled shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chakravarthy Arthi

(Last) (First) (Middle)

C/O ENOVIX CORPORATION

3501 W. WARREN AVENUE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/08/2026		F		936(1)	D	$7.91	413,884(2)	D
Common Stock	01/08/2026		F		3,425(1)	D	$7.91	410,459(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

2. Includes 289,249 shares issuable upon the vesting and settlement of RSUs granted to the Reporting Person and 20,786 shares of vested performance RSUs ("PRSUs"), of which 50% will be released in on March 2, 2026 and the remaining 50% will be released on March 1, 2027. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

3. Includes 282,906 shares issuable upon the vesting and settlement of RSUs granted to the Reporting Person and 20,786 shares of vested PRSUs.

Remarks:

	/s/ Arthi Chakravarthy	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enovix (ENVX) report for Arthi Chakravarthy?

The Chief Legal Officer, Arthi Chakravarthy, reported two transactions on January 8, 2026 in Enovix common stock, both coded F, reflecting shares withheld to cover tax obligations upon vesting of restricted stock units.

How many Enovix shares were withheld for taxes in this Form 4?

The transactions show that 936 shares and 3,425 shares of Enovix common stock, for a combined 4,361 shares, were withheld at a price of $7.91 per share to satisfy tax withholding obligations tied to RSU vesting.

How many Enovix shares does Arthi Chakravarthy own after the reported transactions?

Following the reported withholding transactions, Arthi Chakravarthy beneficially owned 410,459 shares of Enovix common stock directly, as disclosed in the Form 4.

What restricted stock units and performance RSUs are included in the Enovix Form 4?

The filing states that the ownership includes 289,249 shares issuable upon vesting and settlement of RSUs and 20,786 vested performance RSUs (PRSUs). A related line notes 282,906 RSU-based shares plus the same 20,786 vested PRSUs.

When will the vested Enovix performance RSUs reported in this Form 4 be released?

The 20,786 vested PRSUs are scheduled so that 50% will be released on March 2, 2026 and the remaining 50% will be released on March 1, 2027, with each PRSU representing a right to one share of Enovix common stock upon settlement.

Does the Enovix Form 4 indicate open-market selling by the Chief Legal Officer?

No. The transaction code is F, and the footnote explains that the activity reflects withholding of shares of Enovix common stock to satisfy tax withholding obligations in connection with the vesting of RSUs, rather than discretionary open-market sales.